Trends in metastatic breast and prostate cancer - Lessons in cancer dynamics

New England Journal of Medicine

Volumn 373, Issue 18, 2015, Pages 1685-1687

  Welch, H Gilbert ^a   Gorski, David H ^b,c   Albertsen, Peter C ^d  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGE DISTRIBUTION; BREAST CANCER; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; EARLY DIAGNOSIS; HUMAN; MAMMOGRAPHY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREND STUDY; ADULT; BLOOD; BREAST NEOPLASMS; CANCER REGISTRY; FEMALE; INCIDENCE; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATIC NEOPLASMS; TRENDS; UNITED STATES; UTILIZATION;

ADULT; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 84946059255     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1510443     Document Type: Review

References (5)

1. Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK. Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. J Urol 1997;158:1427-30.
2. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009;101: 1325-9.
3. Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012;366:981-90. [Erratum, N Engl J Med 2012;366:2137.]
4. Hellman S. Natural history of small breast cancers. J Clin Oncol 1994;12:2229-34.
5. The GIVIO Investigators. Impact of follow up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994;271:1587-92.